News Archive - Stand Up To Cancer

News

LATEST UPDATES

READ MORE

She’s a stage IV pancreatic cancer survivor, and she’ll be throwing out the first pitch at the World Series tonight

The honored tradition of throwing the ceremonial first pitch will be on full display Saturday night. Here’s the story behind it.

Read More
READ MORE

USPSTF Recommends Starting Colorectal Cancer Screenings at Age 45

The United States Preventative Services Task Force (USPSTF) now recommends that individuals at average risk for colorectal cancer begin routine screenings at age 45 instead of 50.

Read More
READ MORE

‘I Suffered From Strange GI Symptoms For Years Until I Was Finally Diagnosed With Colon Cancer At 35’

Here’s what I want the Black community to know.

Read More
READ MORE

Mount Sinai Team Awarded Grant to Address Racial Disparities in Cancer Trial Participation

The issue of racial and ethnic disparities in health care has moved to the forefront of the medical community and has been further underscored by differences in COVID-19 vaccination rates.

Read More
READ MORE

New Trial to Find Biomarkers to Guide Treatment

Researchers across the world are exploring new ways to more effectively treat metastatic pancreatic cancer.

Read More
READ MORE

Dallas Cowboys QB Dak Prescott Honors Late Mom With Cancer Fundraiser

Dallas Cowboys QB Dak Prescott Honors Late Mom With Cancer Fundraiser

Read More
READ MORE

Study Uses Precision Medicine to Speed Drug Testing for Pancreatic Cancer

Moores Cancer Center at UC San Diego Health is among the few clinical trial sites in the U.S. for the Pancreatic Cancer Action Network’s newly created Precision Promise, the first large-scale precision medicine trial designed to transform outcomes for patients with pancreatic cancer.

Read More
READ MORE

Mirati Therapeutics Donates $4M to Stand Up to Cancer to Advance KRAS-Mutant Cancer Treatment

Stand Up to Cancer (SU2C) and Mirati Therapeutics said on Monday that Mirati has awarded $4 million to SU2C to advance treatment for KRAS-mutant cancers.

Read More
READ MORE

Mirati to contribute $4 million grant to support SU2C research on KRAS mutant cancers

The research will focus on cancer types with unmet medical needs, and the application of tumor-agnostic strategies and molecular testing to address those needs.

Read More
READ MORE

The Dream Team Opens Clinical Trial to Find Better Treatment Options for Pancreatic Cancer

A new team of pioneering pancreatic cancer researchers has been formed to predict which treatments might work best for individual pancreatic cancer patients based on the molecular traits of tumors.

Read More

JOIN OUR COMMUNITY

Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Please validate the captcha
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.